At Omniscope, we read your immune system in high definition: one cell at a time. We are building the world’s largest immune databank. Our vision? Healthcare for everyone, everywhere. 🚀 Thanks for the feature, Google Cloud! 🔗 Learn more about Omniscope technology: https://www.omniscope.ai/ #GoogleCloudSummit #ScienceIsWeAll Google, Vijay Vaswani
About us
Building the world's largest immune databank to inform therapy and develop diagnostics through a convergence of high-resolution immune cell sequencing and artificial intelligence. We bring together bright minds from multiple disciplines. We are driven to shorten the timeline from research to real-world human impact. Our motivation is to put science in service of humanity. Join us in our mission: Healthcare for everyone, everywhere. Science is we all.
- Website
-
http://www.omniscope.ai
External link for Omniscope
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Delaware
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
Delaware, US
-
Barcelona, ES
-
Malta, MT
Employees at Omniscope
-
Jess Emerson Uy 黃 文 俊
-
Helen H. Liang, PhD
Founder & Managing Partner of FoundersX Ventures. Featured on WSJ and Business Insider as a Pioneering Tech VC. Board Director. Invited Speaker at…
-
Luciana Trigo
Making Science Happen | Marketing, Insights & AI | Immune System
-
James Hughes
Chief Executive and Chief Investment Officer at Vedra Partners
Updates
-
Thrilled to present our poster at #ESMO24! Come by Poster 561P to explore how immune characterization and AI tools can offer critical clinical insights. Let’s meet: https://lnkd.in/e-NKrUTd #ScienceIsWeAll #NoTCellLeftBehind ESMO - European Society for Medical Oncology
-
-
Join us at ESMO Congress 2024 to learn how our technologies and AI-powered analysis can elucidate T cell landscape dynamics during immunotherapy treatment. Let’s chat! 🤝 https://lnkd.in/d4AR_C75 #ScienceIsWeAll #ESMO24 ESMO - European Society for Medical Oncology
-
-
Omniscope technology can precisely distinguish and cluster T cell signals from different COVID vaccines, revealing shared sequences across manufacturers. This can help compare vaccines and improve their development. As part of the BAXERNA 2.0 consortium, Omniscope technology will be used to evaluate different mRNA vaccine candidates and their effects on the immune system, to help prioritize best option for development. More info: https://lnkd.in/d3CUMtvw #ScienceIsWeAll
-
-
In latest Omniscope round table discussion, leading experts share groundbreaking insights into immuno-oncology. 🔗 Ready to dive in? Watch the full video here: https://lnkd.in/dPwDmKkX #ScienceIsWeAll
-
Omniscope analyzed pre- and post-HIV infection samples to uncover disease-related immune changes. We successfully revealed an unusual amount of expanded T cells not present before infection in all patients, which could potentially be related to HIV infection. Learn how Omniscope applies its technology to elucidate the impact of infections on the immune system and generate new therapeutic strategies: https://lnkd.in/ekY8DHfd #ScienceIsWeAll
-
-
How is AI transforming healthcare? Vijay Vaswani shares insights on Molecule to Market. Don’t miss out on learning about the next big leap in drug discovery and immune profiling. Catch this episode! 🎧 Spotify: https://lnkd.in/dF2Hxf3K 🎧 Apple: https://lnkd.in/dKvRgKeV 🎧 Amazon: https://lnkd.in/dJbgtfZp #ScienceIsWeAll
-
-
Clonal mapping of CD8+ T cell receptors shows higher clone percentage in responding patients. This suggests peripheral CD8+ clonality can provide information regarding long-term treatment response and inform treatment stratification. 🗞️ https://lnkd.in/dBb8fqMn #ScienceIsWeAll
-
-
´ Excited to feature on Sifted's Early-Stage Drug Discovery Start-Up Watch List! Omniscope provides in-depth, AI-powered, immune dynamics insights across treatment and disease progression to empower patients and clinicians. 🔗 Full article here: https://lnkd.in/e9YnvVJZ
-